whole-genome sequencing:
Category: commercial genetic testing
Forbes' Matthew Herper argues that the long-awaited $1000 genome will never actually materialise, due to the overheads associated with medical interpretation. He's right, for those who plan to obtain their genomes through the traditional medical route. However, those with the motivation to take their genetic information into their own hands will be able to follow an alternative, and more affordable, path - and one that brings its own benefits.
Read on »
Posted by Daniel MacArthur at 10:10 AM • •
Category: next-generation sequencing
Sequencing giant Illumina has announced a stunning price drop for its retail whole-genome sequencing service. It's still not cheap, at $19,500, but it sets the scene for a price war that will ultimately benefit all of us interested in affordable genome sequencing.
Read on »
Posted by Daniel MacArthur at 7:00 PM • 5 Comments •
Category: whole-genome sequencing
A new article in the Lancet describes the most thorough attempt yet made to extract useful clinical information from the whole genome sequence of a healthy individual (researcher Stephen Quake). But how much can a genome really tell us right now?
Read on »
Posted by Daniel MacArthur at 9:00 PM • 13 Comments •
Category: whole-genome sequencing
It's a big week for family genomics. I wrote a couple of days ago about the West family, all four members of which recently had their entire genomes sequenced by Illumina. Now an article in the Salt Lake Tribune reveals...
Read on »
Posted by Daniel MacArthur at 5:40 AM • •
Category: whole-genome sequencing
Sequencing company Illumina has announced that it has sequenced the complete genomes of four members of a nuclear family, including two teenage children. The announcement raises questions about the ethical implications of recreational genomics for children - do the potential harms outweigh the benefits?
Read on »
Posted by Daniel MacArthur at 5:00 PM • 16 Comments •
Category: next-generation sequencing
Actor Glenn Close has had her complete genome sequenced by technology company Illumina. The company has also announced upcoming improvements to its sequencing service, hinting at some strong competition ahead between Illumina and sequencing provider Complete Genomics. That's good news for those of us waiting to get our own genomes sequenced.
Read on »
Posted by Daniel MacArthur at 9:30 AM • 14 Comments •
Category: disease genetics
Two studies released today report the first ever uses of whole genome sequencing to pin down the genetic basis of severe disease. In the process, they illustrate both the promise and the serious challenges ahead as we move into the era of personal whole-genome sequencing.
Read on »
Posted by Daniel MacArthur at 5:00 PM • 11 Comments •
Category: agbt
Two brand new players in next-generation sequencing technology revealed their cards at this week's Advances in Genome Biology and Technology meeting.
Read on »
Posted by Daniel MacArthur at 11:00 AM • •
Category: agbt
Pacific Biosciences unveiled its new third-generation sequencing platform in dramatic style at the Advances in Genome Biology and Technology meeting.
Read on »
Posted by Daniel MacArthur at 5:15 PM • 5 Comments •
Category: agbt
Highlights from the Advances in Genome Biology and Technology meeting in Marco Island, Florida.
Read on »
Posted by Daniel MacArthur at 1:45 PM • 1 Comments •
